Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma.

Autor: Heger JM; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; Cologne Lymphoma Working Group (CLWG), Cologne, Germany.; Mildred Scheel School of Oncology Aachen Bonn Cologne Düsseldorf (MSSO ABCD), Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany., Mammadova L; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany., Mattlener J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany., Sobesky S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany., Cirillo M; University of Western Australia and Royal Perth Hospital, Perth, Australia., Altmüller J; West German Genome Center (WGGC), University of Cologne, Cologne, Germany.; Technology Platform Genomics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Kirst E; West German Genome Center (WGGC), University of Cologne, Cologne, Germany.; Hematopathology Section and Lymph Node Registry, Department of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Reinke S; Hematopathology Section and Lymph Node Registry, Department of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Klapper W; Hematopathology Section and Lymph Node Registry, Department of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Bröckelmann PJ; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; Cologne Lymphoma Working Group (CLWG), Cologne, Germany.; Mildred Scheel School of Oncology Aachen Bonn Cologne Düsseldorf (MSSO ABCD), Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany.; Max Planck Institute for Biology of Ageing, Cologne, Germany., Ferdinandus J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany., Kaul H; German Hodgkin Study Group (GHSG), Cologne, Germany., Schneider G; German Hodgkin Study Group (GHSG), Cologne, Germany., Schneider J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany., Schleifenbaum JK; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; Cologne Lymphoma Working Group (CLWG), Cologne, Germany., Ullrich RT; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany., Freihammer M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany., Awerkiew S; Institute for Virology, University of Cologne, Cologne, Germany., Lohmann M; German Hodgkin Study Group (GHSG), Cologne, Germany.; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, German Cancer Consortium (DKTK Partner Site Essen), Essen, Germany.; Cancer Center Cologne Essen-Partner Site Essen, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Klein F; Institute for Virology, University of Cologne, Cologne, Germany., Nürnberg P; West German Genome Center (WGGC), University of Cologne, Cologne, Germany., Hallek M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany., Rossi D; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Mauz-Körholz C; Pediatric Hematology, Oncology and Immunodeficiencies, Justus-Liebig University of Giessen, Giessen, Germany.; Medical Faculty of the Martin-Luther-University of Halle, Wittenberg, Halle, Germany., Gattenlöhner S; Institute for Pathology, Justus Liebig University Giessen, Giessen, Germany., Bräuninger A; Institute for Pathology, Justus Liebig University Giessen, Giessen, Germany., Borchmann P; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; Cologne Lymphoma Working Group (CLWG), Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany., von Tresckow B; German Hodgkin Study Group (GHSG), Cologne, Germany.; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, German Cancer Consortium (DKTK Partner Site Essen), Essen, Germany.; Cancer Center Cologne Essen-Partner Site Essen, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Borchmann S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; Cancer Center Cologne Essen-Partner Site Cologne, CIO Cologne, University of Cologne, Cologne, Germany.; Cologne Lymphoma Working Group (CLWG), Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Dec 10; Vol. 42 (35), pp. 4218-4230. Date of Electronic Publication: 2024 Sep 30.